Management of appendix tumours, pseudomyxoma peritonei and peritoneal malignancy
11th June 2025, 19:00 to 20:00 BST
Overview
Appendix tumours include a heterogenous group of epithelial and non-epithelial pathologies with varying degrees of malignant potential. These are rare tumours, but it is estimated that the incidence of appendix tumours in appendicectomy specimens is approximately 1%. The diagnosis and treatment of appendix tumours are evolving with a better understanding of their histopathology and molecular characteristics. During this webinar, we will use a multidisciplinary team approach, including discussions with radiologist, pathologist, surgeon, oncologist and clinical nurse specialist to better understand their management.
Aims
Aim is to explore the general management of appendix tumours, pseudomyxoma peritonei and peritoneal malignancy at FRCS level.
Learning Objectives
By the end of this webinar, attendees should be able to:
- Describe histopathology of appendix tumours
- Understand the diagnostic approach including relevant radiology
- Be aware of management principle in a tertiary specialist centre
- Appreciate prognosis and surveillance programme.
Panellists
Our panellists include:
-
Professor Omer Aziz - Consultant Colorectal Surgeon, The Christie Hospital, Manchester, UK
-
Dr Rohit Kochhar - Consultant Radiologist, The Christie Hospital, Manchester, UK
-
Dr Bipasha Chakrabarty - Consultant Histopathologist, The Christie Hospital, Manchester, UK
- Dr Saifee Mullamitha - Consultant Medical Oncologist, The Christie Hospital, Manchester, UK.
-
Rebecca Halstead - Lead CNS Colorectal and Peritoneal Oncology Centre, The Christie Hospital, Manchester, UK
-
Mr Jason Rai - Dukes’ Club Advanced cancer & peritoneal malignancy trainee representative.
CPD
1 Hour
To be eligible to receive CPD hours for webinar attendance you must connect for the full duration of the webinar AND complete the feedback survey.
Visit our FAQ for further information relating to webinar CPD.
Recording
A recording of the webinar will be made available on this page in the days following the live broadcast.
